What Is Lymphoma? Symptoms, Causes, Diagnosis, and Treatment

What Is Lymphoma? Symptoms, Causes, Diagnosis, Treatment, and Prevention

What Is Lymphoma? Symptoms, Causes, Diagnosis, Treatment, and Prevention
Everyday Health
Lymphoma is a form of cancer that usually starts in the body’s lymphatic system. The lymphatic system is part of the immune system, which helps fight disease and infection. It consists of the lymph nodes, spleen, and thymus gland.

Because you have lymph tissue throughout your whole body, lymphoma can start almost anywhere. This type of cancer can affect both adults and children. There are two main categories of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL), which is much more common.

Doctors consider certain lymphomas to be highly treatable. However, this depends on several factors, including a person’s age, the type and severity of the lymphoma, and how early healthcare professionals spotted and started to treat the cancer.

Types of Lymphoma

Within the two main categories of NHL and Hodgkin lymphoma, there are several subtypes. Many more people with lymphoma have NHL than Hodgkin lymphoma.

Non-Hodgkin Lymphoma

NHL describes a group of more than 90 cancers that share similar characteristics. This form of lymphoma can begin in the following cell types:

  • B Lymphocytes (B Cells) These cells make antibodies to fight infections. Most NHL is caused by B cells.
  • T Lymphocytes (T Cells) T cells have several roles, including helping B cells make antibodies and fighting viruses.

They typically develop in the lymph nodes and lymphatic tissue but can sometimes affect bone marrow and blood. Some NHLs are slow-growing, while others can be aggressive. Your treatment options will depend on the type of NHL you have and how advanced it is.

Some of the more common types of NHL include:

  • Diffuse Large B-Cell Lymphoma (DLBCL) This is the most common type of lymphoma, accounting for about 1 in 3 lymphomas. It’s often aggressive but responds well to treatment. DLBCL mostly impacts older adults, though there are several subtypes, including primary mediastinal B-cell lymphoma, which primarily affects young women.
  • Follicular Lymphoma This accounts for about 1 in 5 lymphomas in the United States. These NHLs are typically slow-growing, although some can be aggressive. This type of lymphoma is rare in younger people and is difficult to cure, though patients often live for many years with it. Some follicular lymphomas can turn into fast-growing DLBCL.
  • Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) These are closely related, often slow-growing diseases. Many people with CLL and SLL live long lives. The main difference between the two conditions is that when the cancer cells are found primarily in the lymph nodes, doctors call it SLL. If the cancer cells are found mostly in the bloodstream and bone marrow, it is diagnosed as CLL. It is most common in older adults.
  • Mantle Cell Lymphoma (MCL) MCL is much more prevalent in men than in women. It’s also more likely to affect older people and is challenging to treat. This type accounts for about 5 percent of lymphomas.

Some rarer types of NHL include:

  • Cutaneous T-cell lymphomas
  • Cutaneous B-cell lymphomas
  • Primary central nervous system lymphoma
  • Waldenstrom macroglobulinemia
  • Burkitt lymphoma

Hodgkin Lymphoma

Hodgkin lymphoma, formerly called “Hodgkin’s disease,” is thought to originate in B cells. It can begin anywhere but most often affects lymph nodes in the upper body, such as those located near the chest, neck, or underarms.

This form of lymphoma can spread from one lymph node to another.

Hodgkin lymphoma is most common in people in their early twenties and those over age 55, but it can affect adults and children of any age.

There are two main types of Hodgkin lymphoma: Classical and nodular.

Classical Hodgkin Lymphoma (CHL) CHL is the more common form, accounting for about 9 in 10 cases of Hodgkin lymphoma in developed countries.

People with this form of lymphoma have large, abnormal cells, known as Reed-Sternberg cells, in their lymph nodes. There are four subtypes of classical Hodgkin lymphoma:
  • Nodular sclerosis Hodgkin lymphoma
  • Mixed cellularity Hodgkin lymphoma
  • Lymphocyte-rich Hodgkin lymphoma
  • Lymphocyte-depleted Hodgkin lymphoma.

Nodular Lymphocyte Predominant Hodgkin Lymphoma This rare type of Hodgkin lymphoma leads to abnormally large cells that look like popcorn. It usually starts in the lymph nodes of the neck and underarms.

Graphic titled How Lymphoma Affects the Body shows symptoms including fatigue, swollen lymph nodes, weight loss, night sweats, itching skin, bruising easily, loss of appetite, frequent infections and fever/ chills. Everyday Health logo at bottom
Different types of lymphoma can cause any of these symptoms.Everyday Health

Signs and Symptoms of Lymphoma

Symptoms of Hodgkin lymphoma and non-Hodgkin lymphoma can vary depending on what area of the body is affected and how fast the cancer is growing. To further complicate the issue, some symptoms are not specific to lymphoma — they can resemble those of many less serious illnesses. Patients with Hodgkin and non-Hodgkin lymphoma often present to the doctor’s office thinking they have a cold, flu, or another persistent respiratory infection.

In general, if a person has these symptoms for two or more weeks, a healthcare professional should rule out more serious causes.

These can include:

  • Swelling, or feeling a lump in the lymph nodes of the neck, armpit, or groin area — these are generally persistent but don’t cause pain
  • A fever higher than 103 degrees F (39.5 degrees C) that lasts for two days or longer, or gets better and then comes back
  • Drenching and intense night sweats
  • Unexplained or unwanted weight loss
  • Ongoing fatigue
  • Pain in the chest, abdomen, or bones
  • Coughing or shortness of breath

Causes and Risk Factors of Lymphoma

The exact cause of lymphoma isn’t clear. However, it begins when white blood cells called lymphocytes develop a genetic change that instructs them to multiply. This mutation triggers uncontrolled lymphocyte growth.

Different factors affect your risk of certain types of lymphoma differently. For example, Hodgkins lymphoma is most common in people ages 15 to 40 or over 55, while your risk of NHL is higher after 60 years of age.

You might be at a greater risk for developing lymphoma if the following apply to you:

  • You have a family history of lymphoma.
  • You’ve had certain viruses, such as human immunodeficiency virus (HIV) or Epstein-Barr virus.
  • You have a compromised or weak immune system, for example, after taking immunosuppressant medications following an organ transplant.
  • You’ve had chemotherapy or radiation therapy in the past.

How Is Lymphoma Diagnosed?

The diagnosis of lymphoma begins with a physical exam, looking for swollen lymph nodes in the neck, underarm, groin, and elsewhere. Your doctor might then take a biopsy of a lymph node for laboratory analysis to determine whether the cells are characteristic of lymphoma. This is a sample of cells they sent to a lab for examination under a microscope.

A healthcare professional might take a bone marrow sample with a needle to determine whether it contains lymphoma cells.

Doctors can also take a sample of bone marrow from your hip bone to look for lymphoma cells. They may also order computed tomography, magnetic resonance imagine, or positron emission tomography scans to look for signs of lymphoma elsewhere in the body.

Lymphoma Prognosis

The five-year survival rate describes the percentage of people who are alive at least five years after a cancer diagnosis, compared with those who do not have cancer. It’s important to remember that survival rates are only estimates. Your outlook will depend on several factors, including the type of lymphoma you have and how aggressive your disease is, as well as your age and general health.

According to the American Cancer Society, the overall five-year survival rate for NHL is 74 percent. However, these figures vary by NHL subtype.

The five-year relative survival rate for people with localized Hodgkin lymphoma is about 93 percent. It’s about 83 percent for those with distant-stage disease (when the cancer has spread to areas such as the lungs, liver, or bone marrow).

The survival rates have steadily improved for this type of cancer in recent years. Hodgkin lymphoma is now considered one of the most curable forms of cancer.

While treatment for lymphoma is often successful and can lead to complete remission, for some patients lymphoma may be a chronic illness. The cancer doesn’t go away, but ongoing treatment and close monitoring can help control it. With the right care, lymphoma might not grow or spread for months or years.

Treatment and Medication Options for Lymphoma

Treatment options differ between non-Hodgkin and Hodgkin lymphomas, and treatment will also depend on the stage of the cancer, among other factors. However, people with lymphoma have a wide array of treatment options available, and many are highly effective at curing certain types of lymphoma.

Once your doctor has classified the type of lymphoma, you and your doctor must consider a broad array of possible treatments, each with its own benefits and risks. They may recommend a single treatment or a combination of treatments.

Medication Options

Your healthcare team may suggest many different medications for some types of lymphoma, including those that don’t respond to other treatments or keep coming back.

  • Chemotherapy This uses strong drugs to kill cancer cells or prevent cancer cell growth, and it is one of the main treatments for NHL.

    Often, people with lymphoma receive these drugs through an intravenous drip. Chemotherapy can cause strong side effects, like anemia, nausea, vomiting, and hair loss, as it can also damage normal cells.
  • Immunotherapy During immunotherapy, medication helps the immune system recognize and eliminate cancer cells. Normally, cancer cells can disguise themselves from your immune system, but immunotherapy can help your body detect and destroy them.
  • Targeted Therapy These types of medications target proteins or changes in some lymphoma cells but don’t harm healthy ones. A doctor may recommend targeted therapy if your cancer cells have certain characteristics that medications can target.
  • Steroids These can help make chemotherapy more effective and help your body produce more white blood cells. Doctors might recommend this if you have diffuse large B-cell lymphoma.

Chimeric Antigen Receptor (CAR) T-Cell Therapy

This helps the immune system learn to fight lymphoma. At first, your cancer care team will remove some white blood cells from your blood and send them to a lab. The lab treats the cells, causing them to adapt and develop receptors that can target a marker on the surface of lymphoma cells.

Then, they’ll transfer the cells back into your blood. The cells then get to work finding and destroying lymphoma cells. Tisagenlecleucel (Kymriah) and axicabtagene ciloleucel (Yescarta) are two types of CAR T-cell therapy approved for the treatment of certain B-cell lymphomas.

Radiation Therapy

Radiation therapy uses a type of energy called radiation to damage lymphoma cells. Doctors may use it to treat slow-growing lymphoma that has remained in a limited area of the body, or as a follow-up treatment after chemotherapy for faster-growing lymphomas.

A doctor may also recommend radiation therapy to shrink a lymphoma and reduce symptoms such as pain.

Bone Marrow Transplants

People with some types of lymphoma, and especially those who are younger and with otherwise good health, may receive bone marrow transplants as part of their lymphoma treatment. These involve replacing treatment-damaged bone marrow cells with healthy ones.

Some types of bone marrow transplants, known as autologous transplants, use the body’s own tissue to create stem cells. Others, called allogeneic transplants, may come from a donor.

Lifestyle Changes for Lymphoma

You can’t prevent lymphoma, and controlling many of its risk factors (like age) isn’t possible. However, some lymphoma risk factors are manageable. Generally, your doctor will keep an eye on your progress after treatment and look for recurrences every two to three months.

Reduce Your Risk of HIV and Hep C

HIV and hepatitis C weaken the immune system and are known to increase lymphoma risk.

Therefore, avoiding behavior that increases your risk of these infections, such as intravenous drug use and unprotected sex with multiple partners, might help you to limit your risk.

Treatment is available for HIV and may help mitigate complications.

Plus, studies have found that treating hepatitis C along with NHL can help prevent some cases of NHL from coming back.

Be sure to talk to your doctor about your options.

Look After Your Body Weight and Diet

Maintaining a healthy weight and eating a diet that includes plenty of fruits, vegetables, and whole grains, while limiting highly processed foods, red meats, and drinks with lots of added sugar, may also help you decrease your NHL risk.

Be Aware of Breast Implant Risks

In rare instances, women have developed a type of lymphoma in the scar tissue around breast implants. The risk may be higher with textured implants and tissue expanders than with smooth-surface implants. If you’re thinking about breast implants, you should be aware of these risks and discuss them with your doctor.

Complications of Lymphoma

Treatments for Hodgkin and non-Hodgkin lymphoma are now so varied and effective that many patients will be cured and live long lives after diagnosis and treatment. However, some lymphomas can come back after a successful treatment, even several times a year. And a slow-growing lymphoma might transform into a more aggressive type that has a worse outlook and needs stronger treatments.

But lymphoma treatment can be intensive and might cause complications. Depending on the type of treatment and a person’s overall health, doctors will monitor for:

  • Heart disease
  • Secondary cancers (elsewhere in the body)
  • Lung and bone health
  • Cognitive and memory problems
  • Hormone and thyroid changes
  • Long-term fatigue

Disparities and Inequities in Lymphoma

While non-Hispanic white Americans have the highest risk of both getting and dying from lymphoma, studies have shown that Black populations face challenges around lymphoma treatment, including getting diagnosed at younger ages and facing barriers to accessing high-intensity treatments.

A large-scale analysis that used data from the National Cancer Database found that Black people with diffuse large B-cell lymphoma had a significantly younger age of diagnosis (56 years), compared with white people (66 years). They were also more likely to present with an advanced stage of the cancer at diagnosis, as well as to have symptoms like fever and weight loss.

According to one study, these disparities, including access to appropriate treatment, may be more pronounced for Black people with advanced DLBCL.

For example, Black patients may be less likely to get autologous stem cell transplants or intensive chemotherapy backbones than white patients.

Research has also shown that Black people with lymphoma may also have a lower five-year survival rate than white people and are more likely to experience complications like heart failure, deep vein thrombosis, and pulmonary embolism during treatment.

A complex range of social and biological factors may contribute to these disparities. Further research is necessary to explore why they affect treatment outcomes and how to improve them.

FAQ

Can you live a long life with lymphoma?

Your life expectancy with lymphoma depends on the type you have. Many people live long lives with lymphoma, as some types are slow-growing. Treatment can also send lymphoma into remission or cure it.

Lymphoma symptoms can resemble those of less serious conditions. Only testing, including a biopsy, can identify lymphoma. You might want to get a second opinion to be sure.

Treatment often cures some types of lymphoma or puts them into remission. Other types, however, can be aggressive and fast-growing. Many factors, like age and overall health, can affect how lymphoma responds to treatment.

Viral infections that affect the immune system, like HIV and hepatitis C, have links to increased lymphoma risk. Rheumatoid arthritis, psoriasis, and their immune-suppressing treatments might also slightly increase the risk of lymphoma by affecting the immune system.

Lymphoma is rare. Non-Hodgkin lymphoma is the most common type, with nearly 773,000 people living with or in remission from NHL in the United States. More than 171,000 people in the United States have Hodgkin lymphoma or are in remission.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Lymphatic system. National Cancer Institute.
  2. Lymphoma. Mayo Clinic. September 16, 2025.
  3. Is Lymphoma Curable. Moffitt Cancer Center.
  4. Non-Hodgkin Lymphoma. Cleveland Clinic. February 5, 2025.
  5. Non-Hodgkin Lymphoma. Lymphoma Research Foundation.
  6. What Is Non-Hodgkin Lymphoma? American Cancer Society. February 15, 2024.
  7. Hodgkin Lymphoma. American Cancer Society. October 6, 2025.
  8. Lymphoma. Cleveland Clinic. June 9, 2023.
  9. What Are the Risk Factors for Lymphoma? Roswell Park Comprehensive Cancer Center.
  10. Tests for Non-Hodgkin Lymphoma. American Cancer Society. February 15, 2024.
  11. Survival Rates and Factors That Affect Prognosis (Outlook) for Non-Hodgkin Lymphoma. American Cancer Society. June 27, 2025.
  12. Survival Rates for Hodgkin Lymphoma. American Cancer Society. October 6, 2025.
  13. Blood cancer facts and statistics. Blood Cancer United. April 2024.
  14. Managing Cancer as a Chronic Illness. American Cancer Society. October 10, 2025.
  15. Lymphoma. Mayo Clinic. September 16, 2025.
  16. Treatment options for non-Hodgkin lymphoma. Cancer Research UK. May 8, 2024.
  17. Lymphoma treatment. Blood Cancer UK.
  18. Yuen SS et al. Drugs and Therapeutics Review of Current CAR-T Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Adults: Tisagenlecleucel (Kymriah) and Axicabtagene Ciloleucel (Yescarta). Hong Kong Pharmaceutical Journal. September 2, 2025.
  19. Radiotherapy. Lymphoma Action UK.
  20. Follow up after treatment for non-Hodgkin lymphoma. Cancer Research UK. June 5, 2024.
  21. Hodgkin Lymphoma Causes, Risk Factors, and Prevention. American Cancer Society. October 6, 2025.
  22. Can Non-Hodgkin Lymphoma Be Prevented? American Cancer Society. February 15, 2024.
  23. Lymphoma and HIV. Macmillan Cancer Support.
  24. Honarparvar T et al. Hepatitis C Infection and Non-Hodgkin's Lymphoma: A Case Report and Literature Review. The American Journal of Gastroenterology. October 2024.
  25. Questions and Answers About Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). U.S. Food and Drug Administration. October 23, 2019.
  26. Late effects of treatment for lymphoma. Macmillan Cancer Support.
  27. Ermann DA et al. Racial disparities affecting Black patients with diffuse large B-cell lymphoma. Journal of Clinical Oncology. June 2, 2022.
  28. Herrán M et al. Comparative Outcomes Between Black and White Patients With Early‐Stage Diffuse Large B‐Cell Lymphoma. Cancer Medicine. March 3, 2026.
  29. Gomes MD et al. Racial Differences in the Molecular Genetic Biomarkers of Diffuse Large B-Cell Lymphoma. Biomedicines. November 14, 2025.
  30. Ubah N et al. Racial disparities in health outcomes of patients with diffuse large B-cell lymphoma using real-world data. Blood. November 2025.
walter-tsang-bio

Walter Tsang, MD

Medical Reviewer
Walter Tsang, MD, is a board-certified medical oncologist, hematologist, and lifestyle medicine specialist. Inspired by the ancient Eastern philosophy of yang sheng ("nourishing li...

Lindsey Konkel

Author

Lindsey Konkel is an award-winning freelance journalist with more than 10 years of experience covering health, science, and the environment. Her work has appeared online and in pri...